Trial NCT01035658

View at ClinicalTrials.gov 
Org. Study IDs: SCRI GYN 26

Last trial update was posted on 2021-10-28

MeSH Interventions

Doxorubicin Liposomal doxorubicin

MeSH Conditions

Adenocarcinoma Fallopian Tube Neoplasms Hypersensitivity

Other Conditions

Fallopian Tube Cancer Ovarian Cancer Peritoneal Carcinoma

Stopping Reasons

Based on analyses in Phase I, the study did not advance to Phase II.

Limitations And Caveats

Per protocol, study did not proceed to phase II based on analyses from phase I. Therefore, Phase II outcomes (all outcomes other than determination of the MTD) were not evaluated and will not be posted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID